Evogene Ltd. (EVGN)

Evogene Revenue

Evogene had revenue of $2.44M in the quarter ending March 31, 2025, a decrease of -41.67%. This brings the company's revenue in the last twelve months to $6.77M, down -26.38% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.

• Revenue (ttm): $6.77M
• Revenue Growth: -26.38%
• P/S Ratio: 1.63
• Revenue / Employee: $57,821
• Employees: 117
• Market Cap: 11.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	8.51M	2.87M	50.90%
Dec 31, 2023	5.64M	3.97M	236.72%
Dec 31, 2022	1.68M	745.00K	80.11%
Dec 31, 2021	930.00K	-110.00K	-10.58%
Dec 31, 2020	1.04M	287.00K	38.11%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.